直觉外科Q4业绩超预期，手术机器人需求强劲

Core Insights - The company reported Q4 2025 revenue of $2.87 billion, a 19% year-over-year increase, exceeding analyst expectations of $2.75 billion [1] - Adjusted earnings per share were $2.53, also surpassing analyst forecasts of $2.26 [1] - Surgical volume, including the da Vinci and Ion surgical systems, grew approximately 18% year-over-year [1] - For 2026, the company anticipates global da Vinci-assisted surgeries to grow by 13% to 15%, compared to an 18% growth in 2025 [1]